SUMMARY The relationship between the degree of obesity and the incidence of cardiovascular disease (CVD) THE IMPORTANCE of body weight, body mass and other measures of adiposity in the prediction of cardiovascular disease (CVD) has been the subject of longstanding debate. Many studies have shown that the incidence of certain types of CVD, particularly coronary heart disease and stroke, is greater in heavier persons,'`but only a few suggest that any obesity index makes an additional contribution to risk once the levels of coexisting risk factors are taken into account. '.2'4 Obesity is associated with elevated blood pressure, blood lipids and blood glucose,7 1 and changes in body weight are coincident with changes in these risk factors for disease.", 113 Thus, the consensus has been that the increased risk among heavier persons is due primarily to the influence of the associated risk factor profile and not to the degree of obesity per se. The existing data have also been interpreted to suggest that obesity is benign when it exists without other major risk factors for CVD.
SUMMARY The relationship between the degree of obesity and the incidence of cardiovascular disease (CVD) was reexamined in the 5209 men and women of the original Framingham cohort. Recent observations of disease occurrence over 26 years indicate that obesity, measured by Metropolitan Relative Weight, was a significant independent predictor of CVD, particularly among women. Multiple logistic regression analyses showed that Metropolitan Relative Weight, or percentage of desirable weight, on initial examination predicted 26-year incidence of coronary disease (both angina and coronary disease other than angina), coronary death and congestive heart failure in men independent of age, cholesterol, systolic blood pressure, cigarettes, left ventricular hypertrophy and glucose intolerance. Relative weight in women was also positively and independently associated with coronary disease, stroke, congestive failure, and coronary and CVD death. These data further show that weight gain after the young adult years conveyed an increased risk of CVD in both sexes that could not be attributed either to the initial weight or the levels of the risk factors that may have resulted from weight gain. Intervention in obesity, in addition to the well established risk factors, appears to be an advisable goal in the primary prevention of CVD.
THE IMPORTANCE of body weight, body mass and other measures of adiposity in the prediction of cardiovascular disease (CVD) has been the subject of longstanding debate. Many studies have shown that the incidence of certain types of CVD, particularly coronary heart disease and stroke, is greater in heavier persons,'`but only a few suggest that any obesity index makes an additional contribution to risk once the levels of coexisting risk factors are taken into account. '.2'4 Obesity is associated with elevated blood pressure, blood lipids and blood glucose,7 1 and changes in body weight are coincident with changes in these risk factors for disease.", 113 Thus, the consensus has been that the increased risk among heavier persons is due primarily to the influence of the associated risk factor profile and not to the degree of obesity per se. The existing data have also been interpreted to suggest that obesity is benign when it exists without other major risk factors for CVD.
In this report, we reexamine the obesity question and describe the influence of relative weight on the 26-year incidence of CVD in Framingham men and women. Earlier results from this study suggested that the degree of obesity is not a potent independent risk factor for CVD in general, particularly among women. 14, 15 However, these conclusions were based on analyses of the influence of relative weight over shorter periods of follow-up and may not have conveyed the true impact of disease risk.
Such a reevaluation appears timely in view of the current revisions to the original Metropolitan Life In-surance Company desirable weight tables. 16 These desirable weights, derived from the mortality experiences of subscribers, have been revised upward because new data on insured lives'7 suggest that it is healthier to be heavier than once thought. Recent analyses of long-term mortality in Framingham indicate, however, that this may not be so; minimal mortality occurs at previously published levels of desirable weight.'8 Although recent statistics indicate that the general U.S. population, particularly men, has been getting heavier over the last few decades, 19 20 considerably more data are needed to evaluate the implications of this trend. Likewise, revisions to the desirable weight tables seem premature, because the complex relationships between body weight and health or disease are so poorly understood. This reappraisal of the impact of relative weight on cardiovascular morbidity in Framingham further emphasizes the need for caution, because health-related issues. other than total mortality should be considered in arriving at acceptable levels of desirable weight.
Methods
The Framingham Heart Study population has been examined and followed biennially for the development of CVD since 1948. 21 In this report we present the morbidity experience of 2252 men and 2818 women, ages 28-62 years, who were free of clinically recognizable CVD at the first study examination, which took place between 1949 and 1950. Manifestations of CVD included coronary heart disease, congestive heart failure, stroke and intermittent claudication.
For the purposes of this report, the subjects were classified by weight and other risk attributes at the initial examination only and observed over 26 years for the development of CVD. The obesity index chosen to characterize the population was Metropolitan Relative Weight (MRW), or percentage of desirable weight (the ratio of actual weight to desirable weight x 100). Desirable weight for each sex was derived from the OBESITY AND CARDIOVASCULAR DISEASE/Hubert et al.
1959 Metropolitan Life Insurance Company tables'6 by taking the midpoint of the weight range for the medium build at a specified height. Since desirable weights were reported for subjects wearing both clothes and shoes, these figures were adjusted in order to apply them to Framingham subjects, who were weighed and measured in a dressing gown and without shoes (table 1) .
Other characteristics of interest at the initial examination were systolic blood pressure, measured in the left arm of the seated subjects with a mercury sphygmomanometer and a 14-cm cuff long enough to fit the most obese arm; serum cholesterol concentration, determined by the method of Sperry;22 the number of cigarettes smoked per day, assessed by a physician-administered medical history questionnaire; glucose intolerance, defined by a casual blood glucose level of at least 120 mg%, the presence of glycosuria or a definite history of diabetes; and left ventricular hypertrophy on a 13-lead ECG.
Criteria for each cardiovascular outcome during follow-up were standardized,23 and decisions regarding diagnosis were made by a panel of Framingham investigators. Coronary heart disease included diagnoses of (1) angina pectoris, evidenced by a typical history of chest pain on a physician-administered questionnaire; (2) myocardial infarction, determined by specified electrocardiographic changes, diagnostic elevation of serum enzymes with prolonged ischemic chest pain, or autopsy; (3) coronary insufficiency, defined as prolonged ischemic chest pain accompanied by transient ischemic abnormalities on the ECG; and (4) sudden (in less than 1 hour) or nonsudden coronary death. Congestive heart failure was indicated when at least two major or one major and two minor diagnostic conditions existed concurrently upon examination. 23 The major stroke end point of interest was atherothrombotic brain infarction, defined as the sudden onset of a localizing neurologic deficit lasting over 24 hours without evidence of embolism or hemorrhage. Intermittent claudication was diagnosed from subjective responses to questions on calf cramping during exertion.
Preliminary analyses of the data consisted of calculating crude incidence rates of disease by level of MRW. More formal statistical methods used to assess the influence of MRW independently of the coexisting levels of the major cardiovascular risk factors relied upon multivariate logistic regression procedures24 in which the probability of an event was described as a function of several attributes measured at entry to the Framingham Study. Regression coefficients generated by the logistic model measured the strength of the association between adiposity and the probability of disease after adjustment for age and the other risk factors. The coefficients divided by their standard errors provided tests of significance to indicate whether these relationships were significantly different from zero (p -0.05 when z ¢ 1.96). Standardized coefficients that adjust for differences in measurement units between variables were also calculated to show the impact of weight relative to the other risk factors for disease.
Results
During the 26-year follow-up, 870 men and 688 women developed clinically recognizable CVD. Although some subjects had more than one manifestation of disease, coronary heart disease accounted for a large proportion of the events, 75% and 66% in men dence was most pronounced in those younger than 50 years. This observation was borne out in logistic regression analyses by sex and age group, where the impact of weight was similar in those younger than 40 years and 40-49 years, but greater in these two age groups combined than in the older segment of the cohort. Similar relationships were evident between MRW and coronary disease, the most frequent manifestation of CVD ( fig. 3 ). Incidence also increased with increasing MRW, and the gradient of risk was steeper in the younger men and women. Among men younger than 50 years, the heaviest group experienced twice the risk of coronary disease compared with the leanest group. The risk was increased 2.4-fold among obese women of similar age. The relationships for risk of myocardial infarction were similar to those for total coronary disease ( fig. 4 ). However, there was a much stronger gradient of risk for sudden death with increasing MRW in each age group in both sexes ( fig. 5 ). In fact, these crude rates suggest that the impact of weight on risk may be most pronounced for this outcome. Figure 6 shows that the 26-year incidence of congestive heart failure in the younger men and women increased 2.5-to 3-fold from the leanest to the heaviest subjects. Unlike coronary disease, it appeared that the risk of congestive failure in women was elevated only in the most obese group. MRW had a greater impact on the incidence of atherothrombotic stroke in women than in men ( fig. 7 ). Women younger than 70 years who were 30% or more over desirable weight experienced over four times the stroke rate of the leanest group.
However, not every cardiovascular end point was consistently related to MRW. The 26-year incidence of intermittent claudication, indicative of peripheral vascular disease, did not appear to be clearly related to the degree of overweight in either men or women ( fig. 8 ).
Multivariate logistic regression analyses were undertaken to ascertain whether the strong relationships between weight and disease would persist upon adjustment for the influence of the coexisting levels of the major CVD risk factors. that there was such an interaction effect between weight and its strongest correlate, blood pressure. The magnitude of the standardized regression coefficients indicated that degree of obesity was one of the best predictors of total CVD in women (table 3) . In this group, weight ranked only behind age and blood pressure, while in men it ranked behind all the other risk factors. MRW among males was a better predictor of manifestations of coronary heart disease than blood pressure, cigarette smoking, glucose intolerance or electrocardiographic left ventricular hypertrophy.
It has been argued that obesity does not convey an increased risk of disease unless it is accompanied by elevations in such characteristics as blood pressure or blood lipids. This hypothesis was examined by calculating CVD incidence rates by level of MRW in men and women younger than 50 years of age who were free of risk factors at entry into the study ( fig. 9 ). That is, they were normotensive, had serum cholesterol levels less than 250 mg/dl, did not smoke cigarettes, and had no evidence of glucose intolerance or left ventricular hypertrophy on the ECG. It is not surprising that only 8% of the men and 18% of the women in the highest weight class were free of risk factors. In the subpopulation without major risk factors for disease, CVD incidence rose with increasing weight in both men and women, although the gradient of risk was clearly steeper in males than females. Moreover, logis- gained more weight than men between age 25 and entry, figure 10 shows that the net effect of weight change was greater in males than females. Nonetheless, one could conclude from these data that weight gain into the middle and older ages conveyed an increased risk of disease and weight loss a decreased risk of disease that could not be attributed either to MRW at age 25 years or the levels of the risk factors that may have resulted from weight change. Discussion These data clearly show that the degree of obesity in Framingham men and women was an important longterm predictor of CVD incidence, particularly among the younger members of the cohort. Moreover, obesity in both sexes did not exert its influence on the risk of coronary disease or congestive failure solely through its association with the coexisting risk factors. In women, significant independent relationships were evident for atherothrombotic stroke as well. The lack of association between weight and incidence of intermittent claudication, on the other hand, suggests that the cause of this disorder may be somewhat different from that of the other cardiovascular diseases. These results might also be attributed to underdiagnosis of intermittent claudication in heavier subjects who may not walk or exercise to elicit symptoms with the same frequency as leaner subjects.
It also appears that obesity predisposed to premature CVD in Framingham. Plots of the actuarial life tables for the younger members of the cohort (those younger than 50 years of age at entry to the study) show higher risks for the heaviest compared with the leanest group throughout the 26-year follow-up period ( fig. 1) . However, differences were more pronounced in the younger men than women.
Weight was a relatively potent risk factor for total CVD in women. Only age and blood pressure were more powerful predictors in this group. Male-female differences regarding the impact of obesity on disease The burden of excess weight on the heart also has been shown in autopsy studies in which relative weight was independently related to heart size. 34 35 Obesity has also been associated with the extent of coronary atherosclerosis at autopsy.34 Despite the findings from clinical and experimental studies, there is still much confusion over the complex relationship between obesity and CVD risk. Most epidemiologic studies have been concerned with the impact of overweight on coronary heart disease in men. These studies can be used to highlight some of the difficulties in interpreting and comparing results. For example, the Seven Countries Study showed no significant association between body mass index in most regions and coronary disease incidence over 10 years. However, many of the populations observed were considerably leaner than the Framingham cohort, whose weights compared favorably with those in the general U.S. population.'9 The lack of sufficient heterogeneity in adiposity, and the different cultural and genetic context in which this characteristic may have operated, make comparability between these two studies difficult.
Different indexes of obesity can be differentially related to disease risk,37 which may explain some variability in study results. While body mass index (weight/ height2) has been suggested as the preferred measure of adiposity, in Framingham it was very highly correlated with MRW (r = 0.99) and had no greater predictive power. However, skinfold measurements of subcutaneous fat accumulation correlated with MRW to a lesser degree (r = 0.40-0.65), and preliminary results suggest that these measures were associated somewhat differently with disease risk in Framingham. Furthermore, if indexes of obesity are more powerful predictors of disease in younger than older persons, differences in the age distributions of study populations may also serve to explain what appear to be conflicting results.
The length of follow-up for events in each population can also affect the conclusions drawn from various studies. Some effects of overweight may be evident only after follow-up over long periods of time, as suggested by the importance of duration of obesity on disease. Both the Framingham and Manitoba studies' found obesity to be an independent predictor of disease on long-term observation only. the duration of the study. Among women, the logistic coefficients were fairly strong and consistent in all observation periods. However, statistical significance was not achieved until nearly 14 years of follow-up, for the small number of events in this group resulted in insufficient power to test assumptions. Previous analyses, based on shorter periods of observation, have suggested that there is no independent relationship between MRW and coronary risk in Framingham women.'4 These illustrations clearly show that the accumulated evidence describing the nature of the weight-disease relationship should be interpreted cautiously.
The issue of independence can be resolved only by further study, but we conclude from the existing data that leanness and avoidance of weight gain before middle age are advisable goals in the prevention of CVD for most American men and women. These data further-indicate that intervention on the well-established risk factors for disease should be accompanied by weight loss in the overweight individual. Likewise, revisions to the actuarial desirable weight tables are premature, because such changes suggest that maintenance of heavier weights will not diminish health status. This assumption appears to be unsubstantiated by these as well as other data concerned with the impact of obesity on morbidity and mortality. '2'4' 18 IT IS WELL ESTABLISHED that men have a higher incidence of cardiovascular disease than women. Nonetheless, coronary heart disease (CHD) is the leading cause of death in women (259 deaths/100,000 per year), with women in the United States having high rates compared with the rest of the world.' These statistics belie the relative paucity of research in CHD epidemiology in women. Available data, notably from the Framingham study, support the classic risk factor hypothesis for CHD in women. Women with higher levels of blood cholesterol, high blood pressure, and who smoke cigarettes are more likely to develop CHD than women without these risk factors.2 Other presumed CHD risk factors have been less thoroughly studied in women. For example, several studies associating sedentary living habits with the incidence of CHD in men have been published,3-5 but we are un-aware of any such studies in women. Although the precise role of physical activity in the prevention of CHD is not known, a tenable hypothesis is that more active persons have lower levels of established -risk factors. We previously showed that men who were more physically fit had lower levels of CHD risk than their less physically fit peers. 6 The purpose of this paper is to examine the association between physical fitness and CHD risk factors in women. We hypothesized that women with higher levels of physical fitness have a lower CHD risk.
Methods
More than 3900 adult women, ages 18-65 years, were examined from 1971 to 1980. Some women received only a treadmill test, but 2854 received a complete physical examination, including CHD risk factor measurements. Most of these women were self-referred for the purpose of physical fitness evaluation, periodic health examination or receiving preventive medical advice. These patients tended to be well educated and from middle to upper socioeconomic strata. More than 99% of the women were white. Data reported in this paper are from the first clinic visit for these 977 
